Cargando…
The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
Breast cancer has been reported as the most common cancer in women globally, with 2.26 million new cases in 2020. While anthracyclines are the first-line drug for breast cancer, they cause a variety of adverse reactions and drug resistance, especially for triple-negative breast cancer, which can lea...
Autores principales: | Si, Zihan, Zhong, Yan, Lao, Sixian, Wu, Yufeng, Zhong, Guoping, Zeng, Weiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157424/ https://www.ncbi.nlm.nih.gov/pubmed/35664800 http://dx.doi.org/10.3389/fonc.2022.899145 |
Ejemplares similares
-
The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015) -
Contribution of miRNAs in the Pathogenesis of Breast Cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021) -
Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022) -
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
por: Singh, Shivam, et al.
Publicado: (2023) -
The Influence of EGCG on the Pharmacokinetics and Pharmacodynamics of Bisoprolol and a New Method for Simultaneous Determination of EGCG and Bisoprolol in Rat Plasma
por: Zeng, Weiwei, et al.
Publicado: (2022)